AAAAAA

   
Results: 1-9 |
Results: 9
RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: PAESMANS M SCULIER JP LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Paesmans et al., RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, European journal of cancer, 33(14), 1997, pp. 2326-2332
THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: SCULIER JP PAESMANS M LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC MOMMEN P SERGYSELS R KLASTERSKY J
Citation: Jp. Sculier et al., THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, Revue des maladies respiratoires, 14(6), 1997, pp. 445-449
PROGNOSTIC FACTORS FOR SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG-CANCER - UNIVARIATE AND MULTIVARIATE ANALYSES INCLUDING RECURSIVE PARTITIONING AND AMALGAMATION ALGORITHMS IN 1,052 PATIENTS
Authors: PAESMANS M SCULIER JP LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Paesmans et al., PROGNOSTIC FACTORS FOR SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG-CANCER - UNIVARIATE AND MULTIVARIATE ANALYSES INCLUDING RECURSIVE PARTITIONING AND AMALGAMATION ALGORITHMS IN 1,052 PATIENTS, Journal of clinical oncology, 13(5), 1995, pp. 1221-1230
LONG-TERM SURVIVAL AFTER CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVESIN PATIENTS WITH ADVANCED UNRESECTABLE NONSMALL CELL LUNG-CANCER
Authors: SCULIER JP PAESMANS M LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., LONG-TERM SURVIVAL AFTER CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVESIN PATIENTS WITH ADVANCED UNRESECTABLE NONSMALL CELL LUNG-CANCER, European journal of cancer, 30A(9), 1994, pp. 1342-1347
A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: GOEDHALS L JORDAAN JP KAYE SB ARMAND JP VEENHOF CHN FALKSON G SOUKOP M SCHNEIDER M OBERLING F BUI BN ROCHE H ADENIS L CATY A BLIJHAM GH DEWEWEIRE A COIFFIER B SOTTO JJ VANHEUKELOM LS TAGNON A SLEE PHTJ KROEKS MVAM RAVEZ P CUPISSOL D KEIZER HJ BRUNNER K CALVERT AH YERNAULT JC LIBERT P BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Annals of oncology, 5(7), 1994, pp. 641-643
SMALL-CELL LUNG-CANCER - COMPARISON TO A WEEKLY CHEMOTHERAPY WITH DRUGS WITH A STANDARD CHEMOTHERAPY
Authors: SCULIER JP PAESMANS M BUREAU G DABOUIS G LIBERT P VANDERMOTEN G VANCUTSEM O BERCHIER MC RIES F MICHEL J SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., SMALL-CELL LUNG-CANCER - COMPARISON TO A WEEKLY CHEMOTHERAPY WITH DRUGS WITH A STANDARD CHEMOTHERAPY, Revue des maladies respiratoires, 11(3), 1994, pp. 257-261
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 11(5-6), 1994, pp. 373-384
MULTIPLE-DRUG WEEKLY CHEMOTHERAPY VERSUS STANDARD COMBINATION REGIMENIN SMALL-CELL LUNG-CANCER - A PHASE-III RANDOMIZED STUDY CONDUCTED BYTHE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: SCULIER JP PAESMANS M BUREAU G DABOUIS G LIBERT P VANDERMOTEN G VANCUTSEM O BERCHIER MC RIES F MICHEL J SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., MULTIPLE-DRUG WEEKLY CHEMOTHERAPY VERSUS STANDARD COMBINATION REGIMENIN SMALL-CELL LUNG-CANCER - A PHASE-III RANDOMIZED STUDY CONDUCTED BYTHE EUROPEAN LUNG-CANCER WORKING PARTY, Journal of clinical oncology, 11(10), 1993, pp. 1858-1865
Risultati: 1-9 |